from Wall Street Greek
Week Ahead – Detailed Economic & Corporate Schedule
March 11, 2013
from Wall Street Greek
Cornerstone Therapeutics, Inc. (NASDAQ:CRTX) Investor Alert: Investigation of Takeover Offer
February 25, 2013
Healthcare Stock Gainers (MediciNova, Cornerstone Therapeutics, Threshold Pharmaceuticals, Celldex Therapeutics)
February 20, 2013
Zacks #1 Rank Additions for Thursday – Tale of the Tape
August 30, 2012
Here are 5 stocks added to the Zacks #1 Rank ("strong buy") List today: Acxiom Corp. (ACXM) Arctic Cat Inc. (ACAT) Ciena Corp. (CIEN) CONN'S, Inc. (CONN) Cornerstone Therapeutics, Inc. (CRTX) View the... Read More
category
Zacks
,
Syndicated Content
from Money Morning
category
Business/News/Summary
,
Economic/Reports
from Wall Street Greek
from Wall Street Greek
Weekly Business Calendar
May 09, 2011
from Wall Street Greek
Cornerstone Therapeutics Inc. (CRTX) reported fiscal fourth-quarter earnings of 20 cents per share (excluding special items), which was well above the Zacks Consensus Estimate of a loss of 4 cents. The... Read More
from Stock Blog Hub
Cornerstone Tops Consensus
March 08, 2010
Cornerstone Therapeutics Inc. (NASDAQ:CRTX) reported fiscal fourth-quarter earnings of 20 cents per share (excluding special items), which was well above the Zacks Consensus Estimate of a loss of 4... Read More
from DailyMarkets.com
Pre-Market Earnings (March 4)
March 04, 2010
» Look for the following companies to report earnings Before the Market Opens this morning – Thursday, March 4: US Ecology Inc. (ECOL) Methode Electronics (MEI) Babcock & Brown Air Limited (FLY)... Read More
from Wall Street Pit
(CRTX) Cornerstone Therapeutics Provides Guidance
January 11, 2010
Recently, Cornerstone Therapeutics Inc. (CRTX) forecasted net revenues exceeding $112 million for the year ending December 31, 2010. The guidance for fiscal 2010 assumes that its branded products will... Read More
from Stock Blog Hub
Cornerstone Provides Guidance
January 11, 2010
Recently, Cornerstone Therapeutics Inc. (CRTX) forecasted net revenues exceeding $112 million for the year ending December 31, 2010. The guidance for fiscal 2010 assumes that its branded products will... Read More
from DailyMarkets.com
(CRTX) Cornerstone Therapeutics Tops Consensus Estimates
November 11, 2009
Cornerstone Therapeutics Inc. (CRTX) reported third-quarter earnings per share of 7 cents, compared to a profit of 49 cents in the year-ago quarter. The Zacks Consensus Estimate was pegged at 1 cent.... Read More
from Stock Blog Hub
(CRTX) Cornerstone Therapeutics Wins Factive Rights
September 08, 2009
Last week, Cornerstone Therapeutics Inc. (CRTX) announced the receipt of approval from the United States Bankruptcy Court for Massachusetts district regarding the acquisition of Factive’s (gemifloxacin... Read More
from Stock Blog Hub
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here